Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Apr 25, 2016; 7(8): 175-176
Published online Apr 25, 2016. doi: 10.4239/wjd.v7.i8.175
Published online Apr 25, 2016. doi: 10.4239/wjd.v7.i8.175
Comment on: Statin use and risk of diabetes mellitus
Mehmet Ali Eren, Tevfik Sabuncu, Hüseyin Karaaslan, Department of Endocrinology, Harran University, School of Medicine, 63100 Sanliurfa, Turkey
Author contributions: Eren MA and Karaaslan H wrote this letter; Sabuncu T edited and revised this letter.
Conflict-of-interest statement: None.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Mehmet Ali Eren, MD, Department of Endocrinology, Harran University, School of Medicine, Valikonagi Street, Yenisehir Campus, 63100 Sanliurfa, Turkey. drmalieren@hotmail.com
Telephone: +90-414-3128456
Received: December 11, 2015
Peer-review started: December 14, 2015
First decision: January 4, 2016
Revised: January 22, 2016
Accepted: February 16, 2016
Article in press: February 17, 2016
Published online: April 25, 2016
Processing time: 125 Days and 15.9 Hours
Peer-review started: December 14, 2015
First decision: January 4, 2016
Revised: January 22, 2016
Accepted: February 16, 2016
Article in press: February 17, 2016
Published online: April 25, 2016
Processing time: 125 Days and 15.9 Hours
Abstract
In manuscript named “Statin use and risk of diabetes mellitus” by Chogtu et al, authors defined that pravastatin 40 mg/dL reduced the risk of diabetes by 30% in West of Scotland Coronary Prevention study. In fact, pravastatin 40 mg/dL reduced coronary heart disease risk approximately 30% in mentioned study.
Core tip: We want to eliminate an important error that lead to confusion about the risk of diabetes due to statins in the well-written manuscript by Chogtu et al.